Guo Rui Yinuo received satisfactory evaluations for all results in the 2024 clinical laboratory testing proficiency testing program.


Xixian New Area Guorui Yinuo Drug Safety Evaluation and Research Co., Ltd. (hereinafter referred to as "Guorui Yinuo") has successfully passed the 2024 proficiency testing programs for hematological indicators (NIFDC-PT-475), coagulation indicators (NIFDC-PT-476), and urinary biochemical indicators (NIFDC-PT-477), organized by the National Institute for Food and Drug Control, under its GLP system. All the proficiency testing results reported by the company achieved satisfactory outcomes.

 

Xixian New Area Guorui Yinuo Drug Safety Evaluation and Research Co., Ltd. (hereinafter referred to as "Guorui Yinuo") GLP The clinical laboratory under the system successfully passed the assessment organized by the China National Institute for Food and Drug Control. 2024 Annual Hematology Indicator Testing Proficiency Verification NIFDC-PT-475 ) – Proficiency Testing for Coagulation Parameters NIFDC-PT-476 ) – Proficiency testing for urinary biochemical indicators NIFDC-PT-477 ) The activity showed that all reported proficiency testing results achieved satisfactory outcomes.

This clinical laboratory proficiency testing program involved a total of three tests, namely hematology parameter detection ( NIFDC-PT-475 )、Coagulation indicator testing ( NIFDC-PT-476 ) and urinary biochemical indicator testing ( NIFDC-PT-477 ). Among these, hematology includes 8 The indicators, including hemostasis, are: 2 One indicator, urinary biochemistry includes: 10 One indicator. Upon receipt of the test samples, the Clinical Laboratory of the Clinical Pathology Department at Guorui Yinuo dissolves the samples and swiftly completes the testing for each indicator, then submits the verification results. Ultimately, all indicators are... 100 Pass (with a satisfactory evaluation result) the proficiency testing.

Guorei Yinuo Clinical Laboratory is equipped with cutting-edge international instruments and equipment, including the ADVIA 2120I hematology analyzer, the STAGO coagulation analyzer, and the CLINITEK Status+ urinalysis analyzer. These state-of-the-art devices enable us to perform a wide range of laboratory tests across multiple disciplines, such as hematology, coagulation testing, and urinary biochemistry analysis. The results of this proficiency testing program demonstrate that Guorei Yinuo has established a comprehensive, scientific, and rigorous testing capability and quality management system in strict accordance with GLP standards and requirements. This signifies that every piece of test data issued by Guorei Yinuo is highly reliable and of guaranteed quality, indicating that Guorei Yinuo is fully capable of providing dependable and standardized data support for pharmacotoxicology research.

Guo Rui Yinuo not only established compliance with GLP We have a standardized clinical laboratory workflow and a professional team dedicated to clinical pathology research. Our clinical testing capabilities and quality both meet the highest domestic standards, enabling us to perform tests that comply with Chinese regulations. NMPA Standardized clinical testing. In the future, Guorui Yinuo will continue to uphold the spirit of striving for excellence and constantly seeking innovation, continuously strengthening technological development across all its platforms, continually optimizing quality management, and obtaining more internationally and domestically recognized industry authorities and standard certifications, thereby better serving the field of drug toxicology.